Given the implication of both AR and SEMA3C in prostate cancer development, in combination with the discovery of ARBSs within the SEMA3C locus, we hypothesized that SEMA3C is a transcriptional target of the androgen receptor. The gene discussed is SEMA3C; the disease is prostate cancer.